Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Frontline inotuzumab ozogamicin in older adults with Philadelphia chromosome-negative B-ALL: an exploratory pooled analysis of efficacy and safety

Older adults (aged ≥ 55 years) with Philadelphia chromosome-neg-ative B-cell acute lymphoblastic leukemia (B-ALL) frequently present with adverse cytogenetic features, poor treatment tolerance, and inferior long-term outcomes [1, 2]. While intensive chemotherapy remains the standard first-line approach, its clinical ef...

Kai-Hang Shi, Jing Zhou, Gao-Xiang Wang · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.